Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer

Description

This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of disease prior to surgical and oncologic management. The study will investigate any incremental added benefit to breast MRI specificity by the addition of concurrent hybrid breast PET.

Study Start Date

March, 15 2018

Estimated Completion Date

September 2020

Interventions

  • Diagnostic Test: Hybrid breast FDG PET/MRI

Study ID

Weill Medical College of Cornell University -- 1705018188

Status

Recruiting

Trial ID

NCT03510988

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

147

Sponsor

Weill Medical College of Cornell University

Inclusion Criteria

  • Women over age of 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care

Exclusion Criteria

  • Male subjects
  • Women younger than 25
  • Pregnant subjects
  • Unable or unwilling to undergo MRI
  • Previous adverse reaction to 18F-FDG
  • Unwilling to undergo biopsy of MRI positive lesions

Gender

Female

Ages

25 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Weill Cornell Medical College - New York, New York 50.7 miles Eileen Chang None None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.